A double blind, randomized, vehicle controlled, crossover study with an open-label long-term extension, to evaluate the safety and efficacy of topical naloxone hydrochloride lotion, 0.5%, for the relief of pruritus in patients with the mycosis fungoides (

Project: Research project

Project Details

Effective start/end date2/22/172/21/23


  • Elorac, Inc. (No.EL-1007-01-01//R01FD005396)
  • Food and Drug Administration (No.EL-1007-01-01//R01FD005396)